During the nine months of 2026, residents of the Krasnodar Territory spent 1.9 billion rubles on drugs based on semaglutide (analogues of Ozempi), which is 1.6 times more than a year earlier, RBC reports, citing data from the DSM group. In physical terms, sales increased by 70%, to 354.1 thousand packages. At the same time, the costs of the analogues of the drug "Mongero" in the region increased 16.5 times and reached 3.1 billion rubles.